“Dupilumab With Concomitant Topical Corticosteroids in Atopic Dermatitis Patients Who Are Inadequately Controlled With or Medically Inadvisable for Cyclosporine A: A Phase 3 Clinical Trial (LIBERTY AD CAFE)”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s37. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/200.